The national health system (GHS) will see a slight decline in reserves over the next two years due to costly innovative drugs and overseas treatment costs, but will maintain strong financial stability through 2032, according to an updated actuarial study. The system’s reserves are projected to decrease from €647 million in 2024 to €635 million … Continue reading GHS reserves to dip but remain stable through 2032, study finds